Search

PROCEPT BioRobotics Corp

Затворен

СекторЗдравеопазване

20.28 2.68

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

20.28

Максимум

21.21

Ключови измерители

By Trading Economics

Приходи

-1.8M

-32M

Продажби

6.7M

83M

EPS

-0.56

Марж на печалбата

-38.058

Служители

888

EBITDA

-7.3M

-29M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+13.33% upside

Дивиденти

By Acuity

Следващи печалби

3.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-325M

1B

Предишно отваряне

17.6

Предишно затваряне

20.28

Настроения в новините

By Acuity

50%

50%

128 / 340 Класиране в Healthcare

PROCEPT BioRobotics Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

7.08.2026 г., 20:02 ч. UTC

News

Procept Biorobotics shares are higher as analysts adjust ratings; Wells Fargo sets target at $19.00, while UBS downgrades to "neutral" with a $20.00 target.

6.08.2026 г., 20:03 ч. UTC

Procept Biorobotics shares are higher Thursday, recovering from an earlier decline. The stock closed above its 20-day moving average amid broader market dynamics.

5.08.2026 г., 19:52 ч. UTC

News

Procept Biorobotics shares are higher as TD Cowen maintains a Buy rating and Piper Sandler reiterates its Overweight rating amid increased investor engagement.

4.08.2026 г., 23:02 ч. UTC

News

Procept Biorobotics reported a second-quarter loss of $26.9 million and shares are trading lower in after-market hours following the earnings report.

3.08.2026 г., 20:03 ч. UTC

News

Procept Biorobotics shares decline amid a securities class action lawsuit alleging financial misrepresentation through inflated sales and excess inventory.

31.07.2026 г., 20:02 ч. UTC

News

Procept Biorobotics shares are rising today, even after UBS downgraded its rating to neutral with a $20 price target.

30.07.2026 г., 19:58 ч. UTC

Procept Biorobotics Corp is rising during Thursday's session, driven by a broader market rally and recovery in technology shares. No specific company news was identified.

29.07.2026 г., 16:26 ч. UTC

Procept Biorobotics Corp shares are higher Wednesday, recovering from earlier losses amid broader market volatility ahead of the Federal Reserve's interest rate decision.

28.07.2026 г., 19:26 ч. UTC

Procept Biorobotics Corp shares are trading higher, reflecting a cumulative gain since Monday, despite negative sentiment from declines in Asian markets.

27.07.2026 г., 17:02 ч. UTC

News

Procept Biorobotics reported Q1 revenue of $83.1 million, a 20% increase. Shares are trading higher, recovering from recent declines since Friday's close.

22.07.2026 г., 19:41 ч. UTC

Procept Biorobotics Corp shares are lower today, diverging from recent gains. Broader market concerns include rising crude oil prices and inflationary pressures.

21.07.2026 г., 16:01 ч. UTC

Procept Biorobotics Corp is declining during Tuesday's session, breaking a trend of higher daily closes. No specific news was identified for the move.

20.07.2026 г., 19:56 ч. UTC

Procept Biorobotics Corp shares are higher today, despite earlier volatility and no specific news. Broader market performance remains mixed amid geopolitical tensions.

Сравнение с други в отрасъла

Ценова промяна

PROCEPT BioRobotics Corp Прогноза

Ценова цел

By TipRanks

13.33% нагоре

12-месечна прогноза

Среден 23.13 USD  13.33%

Висок 29 USD

Нисък 19 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за PROCEPT BioRobotics Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

11 ratings

3

Купи

7

Задържане

1

Продай

Настроение

By Acuity

128 / 340 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
help-icon Live chat